ArticleIn vivo (Athens, Greece)
The Correlation Between Aortic Stenosis and the Incidence of Subsequent Ocular Surface Diseases.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimAortic stenosis (AS) is a fatal cardiovascular disease associated with metabolic syndrome and inflammation. Ocular surface diseases are also characterized by elevated inflammatory responses. Therefore, this study aimed to investigate the correlation between AS and the subsequent development of ocular surface diseases, including dry eye disease (DED) and superficial keratopathy. PATIENTS AND
methodsA retrospective cohort study was performed via the usage of the TriNetX database. The patients were divided according to the presence of AS and a total of 421,253 patients were enrolled into both the AS and non-AS groups. The primary outcomes were the development of DED and superficial keratitis after AS. The Cox proportional hazard regression was applied to calculate the adjusted hazard ratio (aHR) and 95% confidence interval (CI) of primary outcomes between groups.
resultsThere were 11,915 and 8,260 DED episodes in the AS and the non-AS groups, respectively. Also, there were 1,409 and 1,038 superficial keratopathy events in the AS and non-AS groups, respectively. After adjusting for all the confounders, the AS group showed a significant higher incidence of DED (aHR=1.375, 95%CI=1.337-1.414,
conclusionThe presence of AS associates with a higher risk of subsequent DED and superficial keratopathy development, which positively relate to the duration of AS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.